Tamoxifen in advanced breast cancer
- 30 September 1978
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 5 (3), 131-141
- https://doi.org/10.1016/s0305-7372(78)80017-6
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Antiöstrogene Therapie des metastasierenden Mammakarzinoms*Deutsche Medizinische Wochenschrift (1946), 1977
- Assessment of response to therapy in advanced breast cancerEuropean Journal of Cancer (1965), 1977
- Plasma hormones in patients with advanced breast cancer treated with tamoxifenEuropean Journal of Cancer (1965), 1976
- Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.BMJ, 1975
- Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptorEuropean Journal of Cancer (1965), 1975
- 2α,3α-epithio-5α-androstan-17β-ol in the treatment of advanced breast cancer. Japanese cooperative group of hormonal treatment for breast cancerCancer, 1973
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971
- A NEW DERIVATIVE OF TRIPHENYLETHYLENE: EFFECT ON IMPLANTATION AND MODE OF ACTION IN RATSReproduction, 1967
- MODE OF ACTION OF I.C.I. 46,474 IN PREVENTING IMPLANTATION IN RATSJournal of Endocrinology, 1967
- Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted TriphenylethylenesNature, 1966